A Decade of Digital Innovation
Patient Information Leaflets provide patients with important guidance on their medications - especially regarding safe and correct use. This requires information that is easily accessible, understandable, and up-to-date.
With this idea in mind, the GI 4.0® (Electronic Package Leaflet) project was launched in April 2016, based on a joint concept paper by European pharmaceutical associations and the German federal government’s Industry 4.0 strategy.
The GI 4.0® digital system has been available to patients free of charge and without advertising since 2020 and makes an important contribution to modern patient information. It provides reliable digital access to officially approved medication information.
The benefits of GI 4.0®:
-
Up-to-date information is available at any time - even offline
-
Clear digital layout with individually accessible chapters and customizable font size
-
Simple search function for quick access to relevant content
-
Clear summary of changes in individual chapters
-
Direct links to training and supplementary materials
Patients can access information about their medications free of charge via the GI 4.0® app (iOS & Android) or the website: https://gebrauchsinformation4-0.de
GI 4.0® is continuously being developed - the project is backed by a unique consortium in Europe comprising pharmaceutical companies, associations, and patient organizations that are working together on forward-looking, digital medication information.
For more information, please visit our website: https://rote-liste.com/en/gi-4.0-and-patienteninfo-service